CeriBell, Inc. (CBLL) Guidance & Earnings Results

On 2026-08-10 CeriBell, Inc. raised guidance: "Revenue guidance raised to $114-117M from prior…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CBLLCeriBell, Inc.Follow CBLL — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 1.0B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 9 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
10 Aug 26	Raised	Revenue guidance raised to $114-117M from prior range · full year
11 May 26	Raised	FY2026 revenue guidance raised to $112M-$116M (26-30% growth) · full year
24 Feb 26	Raised	2026 revenue $111M-$115M (25-29% growth) · full year
4 Nov 25	Raised	FY2025 revenue guidance raised to $87-89M from prior range · full year
5 Aug 25	Raised	FY2025 revenue raised to $85-88M from prior range (not stated); representing 30-34% growth over prior year. · full year

CeriBell, Inc. — questions

What guidance did CeriBell, Inc. give?: On 2026-08-10: "Revenue guidance raised to $114-117M from prior range"
When does CeriBell, Inc. report earnings?: CeriBell, Inc.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from CeriBell, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.